Evidence map›Paper›PMID 37477843›Full record

ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2023

Drivers and barriers to COVID-19 vaccination in Australians with cancer.

Christie Allan, Amelia Hyatt, Amanda Appathurai, Megan Crane, Chhay Lim, Rachel Woolstencroft, Monica A Slavin, Amanda Piper, Danielle Spence, Benjamin W Teh

Abstract read
PubMed Publisher
In one paragraph

Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Drivers and barriers to COVID-19 vaccination in cases with cancer: correspondence.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Christie AllanStrategy and Support Division, Cancer Council Victoria, Melbourne, Victoria, Australia. christie.allan@cancervic.org.au.
Amelia HyattSir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.
Amanda AppathuraiNational Centre for Infections in Cancer, Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Megan CraneNational Centre for Infections in Cancer, Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Chhay LimNational Centre for Infections in Cancer, Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Rachel WoolstencroftNational Centre for Infections in Cancer, Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Monica A SlavinSir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.
Amanda PiperStrategy and Support Division, Cancer Council Victoria, Melbourne, Victoria, Australia.
Danielle SpenceStrategy and Support Division, Cancer Council Victoria, Melbourne, Victoria, Australia.
Benjamin W TehSir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.
Peter MacCallum Cancer Centre · AUCancer Council Victoria · AUUniversity of Melbourne · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo understand the drivers and barriers for COVID-19 vaccination in people with cancer in Australia.

methodsA cross-sectional, online survey, distributed nationally following the establishment of community vaccination programs, wider availability of COVID-19 vaccines and emergence of new variants. Consisting of 21 questions, the survey was designed to determine the behavioural and social drivers of vaccination, participant demographics, underlying disease and treatment, and vaccination status. It was open from the 10th of August 2021 to the 7th of September 2021, recruiting people who had a previous history of cancer (diagnosed or treated in the past 5 years).

resultsA total of 1506 responses were included in the final analysis. Overall, 87.8% reported a positive attitude toward vaccination and 83.1% had received at least one dose of a COVID-19 vaccine. Perceived risk of COVID-19 infection (for self and others) and engagement with a trusted health professional were key drivers for vaccination, while concerns about vaccine development, safety and side effects were barriers. Concerns about vaccination mostly stemmed from a place of misinformation, rather than a broader disregard of vaccines. Just over a third (497, 34.3%) of the respondents were concerned that the vaccine would impact their cancer treatment.

conclusionOverall, participants had positive attitudes toward COVID-19 vaccination and thought it was safe. Findings supported the role of health professionals and cancer organisations as trusted information providers and calls for more, credible information to help people with cancer make informed decisions about the COVID-19 vaccine.

Indexed as

COVID-19COVID-19 VaccinesNeoplasmsPatient Acceptance of Health CareAustralasian PeopleAustraliaCross-Sectional StudiesHealth Care SurveysHealth EducationHumansVaccinationCOVID-19 VaccinesCancerCOVID-19COVID-19 vaccineVaccination

Identifiers

PMID37477843
OpenAlexW4384924687

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.